Cancer
USP9Y (HLA-A*01:01) IVDCLTEMY
Product number: EP11448_5
€210.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
IVDCLTEMY is a linear peptidic epitope (epitope ID29227) studied as part of Probable ubiquitin carboxyl-terminal hydrolase FAF-Y from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
TechData
| Sequence: | IVDCLTEMY |
| Gene: | USP9Y |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Ubiquitin carboxyl-terminal hydrolase 9Y |
| UniProt Id: | O00507 |
| IEDB Id: | 29227 |
| Species: | Human |
| Allele: | HLA-A*01:01, HLA-A*11:01, HLA-B*15:01 |
| Application: | Immune monitoring, Immunohistochemistry, T-cell assays |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |